XML 39 R27.htm IDEA: XBRL DOCUMENT
v3.21.2

Revenue (Tables) | 9 Months Ended
--- | ---
Oct. 01, 2021
Revenue from Contract with Customer [Abstract] |
Disaggregation of Revenue | The following tables present the Company’s revenues disaggregated by geographical region and revenue type for the three and nine-month periods ended October 1, 2021 and October 2, 2020 ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenue.
| Life Sciences |  | Diagnostics |  | Environmental & Applied Solutions |  | Total
For the Three-Month Period Ended October 1, 2021: |  |  |  |  |  |  |
Geographical region: |  |  |  |  |  |  |
North America | $ | 1,291 |  |  | $ | 1,083 |  |  | $ | 512 |  |  | $ | 2,886 |
Western Europe | 989 |  |  | 424 |  |  | 256 |  |  | 1,669 |
Other developed markets | 202 |  |  | 126 |  |  | 28 |  |  | 356 |
High-growth markets (a) | 1,150 |  |  | 816 |  |  | 352 |  |  | 2,318 |
Total | $ | 3,632 |  |  | $ | 2,449 |  |  | $ | 1,148 |  |  | $ | 7,229 |
Revenue type: |  |  |  |  |  |  |
Recurring | $ | 2,591 |  |  | $ | 2,150 |  |  | $ | 678 |  |  | $ | 5,419 |
Nonrecurring | 1,041 |  |  | 299 |  |  | 470 |  |  | 1,810 |
Total | $ | 3,632 |  |  | $ | 2,449 |  |  | $ | 1,148 |  |  | $ | 7,229 |
For the Three-Month Period Ended October 2, 2020: |  |  |  |  |  |  |
Geographical region: |  |  |  |  |  |  |
North America | $ | 1,101 |  |  | $ | 798 |  |  | $ | 481 |  |  | $ | 2,380 |
Western Europe | 780 |  |  | 349 |  |  | 245 |  |  | 1,374 |
Other developed markets | 193 |  |  | 104 |  |  | 29 |  |  | 326 |
High-growth markets (a) | 849 |  |  | 638 |  |  | 317 |  |  | 1,804 |
Total | $ | 2,923 |  |  | $ | 1,889 |  |  | $ | 1,072 |  |  | $ | 5,884 |
Revenue type: |  |  |  |  |  |  |
Recurring | $ | 2,076 |  |  | $ | 1,542 |  |  | $ | 610 |  |  | $ | 4,228 |
Nonrecurring | 847 |  |  | 347 |  |  | 462 |  |  | 1,656 |
Total | $ | 2,923 |  |  | $ | 1,889 |  |  | $ | 1,072 |  |  | $ | 5,884 |
(a) The Company defines high-growth markets as developing markets of the world experiencing extended periods of accelerated growth in gross domestic product and infrastructure which include Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan, Australia and New Zealand). The Company defines developed markets as all markets that are not high-growth markets.
| Life Sciences |  | Diagnostics |  | Environmental & Applied Solutions |  | Total
For the Nine-Month Period Ended October 1, 2021: |  |  |  |  |  |  |
Geographical region: |  |  |  |  |  |  |
North America | $ | 3,903 |  |  | $ | 3,025 |  |  | $ | 1,501 |  |  | $ | 8,429 |
Western Europe | 3,011 |  |  | 1,282 |  |  | 810 |  |  | 5,103 |
Other developed markets | 636 |  |  | 355 |  |  | 87 |  |  | 1,078 |
High-growth markets (a) | 3,362 |  |  | 2,301 |  |  | 1,032 |  |  | 6,695 |
Total | $ | 10,912 |  |  | $ | 6,963 |  |  | $ | 3,430 |  |  | $ | 21,305 |
Revenue type: |  |  |  |  |  |  |
Recurring | $ | 7,760 |  |  | $ | 6,074 |  |  | $ | 1,984 |  |  | $ | 15,818 |
Nonrecurring | 3,152 |  |  | 889 |  |  | 1,446 |  |  | 5,487 |
Total | $ | 10,912 |  |  | $ | 6,963 |  |  | $ | 3,430 |  |  | $ | 21,305 |
For the Nine-Month Period Ended October 2, 2020: |  |  |  |  |  |  |
Geographical region: |  |  |  |  |  |  |
North America | $ | 2,721 |  |  | $ | 2,244 |  |  | $ | 1,430 |  |  | $ | 6,395 |
Western Europe | 1,963 |  |  | 974 |  |  | 721 |  |  | 3,658 |
Other developed markets | 524 |  |  | 298 |  |  | 88 |  |  | 910 |
High-growth markets (a) | 2,007 |  |  | 1,660 |  |  | 894 |  |  | 4,561 |
Total | $ | 7,215 |  |  | $ | 5,176 |  |  | $ | 3,133 |  |  | $ | 15,524 |
Revenue type: |  |  |  |  |  |  |
Recurring | $ | 5,135 |  |  | $ | 4,305 |  |  | $ | 1,810 |  |  | $ | 11,250 |
Nonrecurring | 2,080 |  |  | 871 |  |  | 1,323 |  |  | 4,274 |
Total | $ | 7,215 |  |  | $ | 5,176 |  |  | $ | 3,133 |  |  | $ | 15,524 |
(a) The Company defines high-growth markets as developing markets of the world experiencing extended periods of accelerated growth in gross domestic product and infrastructure which include Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan, Australia and New Zealand). The Company defines developed markets as all markets that are not high-growth markets.

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration